Tue, August 31, 2021
Mon, August 30, 2021
Fri, August 27, 2021
Thu, August 26, 2021
Wed, August 25, 2021
Tue, August 24, 2021
Mon, August 23, 2021
Fri, August 20, 2021
Thu, August 19, 2021
Wed, August 18, 2021
Tue, August 17, 2021

Marc Frahm Downgraded (TBPH) to Hold and Decreased Target to $14 on, Aug 24th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-decreased-target-to-14-on-aug-24th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Marc Frahm of Cowen & Co., Downgraded "Theravance Biopharma, Inc." (TBPH) to Hold and Decreased Target from $42 to $14 on, Aug 24th, 2021.

Marc has made no other calls on TBPH in the last 4 months.



There is 1 other peer that has a rating on TBPH. Out of the 1 peers that are also analyzing TBPH, 0 agree with Marc's Rating of Hold.



This is the rating of the analyst that currently disagrees with Marc


  • Vikram Purohit of "Morgan Stanley" Maintained at Buy with Decreased Target to $27 on, Friday, July 16th, 2021

Publication Contributing Sources